tepid us sales to hurt sun pharma q1 fy21 results?
Published 4 years ago • 181 plays • Length 1:36
Download video MP4
Download video MP3
Similar videos
-
3:06
sun pharma reports q1'fy21 results with consolidated sales from operations at `7,467 crores
-
2:55
sun pharma q1 fy21 review | why are brokerages mixed?
-
1:10
sun pharma to announce its financial results today of q1
-
1:39
sun pharma q1 results: pat dips 2% yoy to rs 2,023 cr on one-time expense
-
1:27
what should we expect from sun pharma's results this quarter? | et now | business news
-
1:40
stock market morning minute, monday, oct. 21 (ba, ups, luv)
-
12:43
the big 3: asml, pltr, ibm
-
3:39
sun pharma q4 results: net profit beats estimates by surging to 33%
-
3:05
sun pharma 3q fy21: margins beat estimations
-
4:40
sun pharma: mixed q1 earnings for company, what are the key growth driver for global performance?
-
0:32
top 5 pharma sector company in india | best stock #shorts #youtubeshorts
-
6:39
sun pharma reports a largely in-line set of q4 numbers; us sales come in at $430 m | cnbc tv18
-
2:26
sun pharma offers to acquire remaining stake in taro in an all-cash deal: key details
-
2:11
sun pharma q4 | ebitda misses estimates
-
4:33
sun pharma margins trend to sustain in coming quarters? | cs muralidharan explains | et now
-
0:35
sun pharma q4 profit in line with estimates
-
0:39
sun pharma q3 net profit tanks 26% to rs 913 crore
-
5:32
growth witnessed across most therapies | c s muralidharan, sun pharmaceutical industries
-
7:16
sun pharma q1 results: net profit up 40%, revenue gains; margins flat
-
1:45
sun pharma and glenmark recall products in us due to manufacturing issues
-
2:52
covid setback likely for tata motors; nifty steady above 11,000 mark | top headlines
Clip.africa.com - Privacy-policy